148 related articles for article (PubMed ID: 25208979)
1. Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: a meta-analysis.
Zheng Z; Liang W; Wang D; Schroder PM; Ju W; Wu L; Zheng Z; Shang Y; Guo Z; He X
Int J Cancer; 2015 Mar; 136(6):E751-9. PubMed ID: 25208979
[TBL] [Abstract][Full Text] [Related]
2. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma.
Feng X; Feng GY; Tao J; Ao YP; Wu XH; Qi SG; Shi ZR
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10505-10518. PubMed ID: 37284841
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
Liao M; Zhu Z; Wang H; Huang J
Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies.
Marelli L; Stigliano R; Triantos C; Senzolo M; Cholongitas E; Davies N; Yu D; Meyer T; Patch DW; Burroughs AK
Cancer Treat Rev; 2006 Dec; 32(8):594-606. PubMed ID: 17045407
[TBL] [Abstract][Full Text] [Related]
7. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Shen A; Liu M; Zheng D; Chen Q; Wu Z
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
[TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Miyazaki I
Hepatogastroenterology; 1996; 43(12):1415-20. PubMed ID: 8975941
[TBL] [Abstract][Full Text] [Related]
10. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis.
Liang L; Li C; Diao YK; Jia HD; Xing H; Pawlik TM; Lau WY; Shen F; Huang DS; Zhang CW; Yang T
Therap Adv Gastroenterol; 2020; 13():1756284820977693. PubMed ID: 33329759
[TBL] [Abstract][Full Text] [Related]
11. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
[TBL] [Abstract][Full Text] [Related]
12. Preoperative transarterial chemoembolization for hepatocellular carcinoma.
Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
Hepatogastroenterology; 2012 Oct; 59(119):2295-9. PubMed ID: 23435144
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus.
Peng BG; He Q; Li JP; Zhou F
Am J Surg; 2009 Sep; 198(3):313-8. PubMed ID: 19285298
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma.
Yeh ML; Huang CI; Huang CF; Hsieh MY; Huang JF; Dai CY; Lin ZY; Chen SC; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2015 Feb; 31(2):77-82. PubMed ID: 25645985
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
[TBL] [Abstract][Full Text] [Related]
16. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
[TBL] [Abstract][Full Text] [Related]
17. The effect of postoperative TACE on prognosis of HCC with microscopic venous invasion.
Ke-Wei L; Tian-Fu W; Xi L; Lü-Nan Y; Bo L; Yong Z; Wu-Sheng L; Wen-Tao W; Ming-Qing X; Jia-Yin Y; Yu-Kui M; Zhe-Yu C
Hepatogastroenterology; 2012 Sep; 59(118):1944-6. PubMed ID: 22246191
[TBL] [Abstract][Full Text] [Related]
18. Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? A meta-analysis.
Hu L; Zheng Y; Lin J; Shi X; Wang A
World J Surg Oncol; 2023 Apr; 21(1):121. PubMed ID: 37013589
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of adjuvant i(131) lipiodol after excision of hepatocellular carcinoma.
Furtado R; Crawford M; Sandroussi C
Ann Surg Oncol; 2014 Aug; 21(8):2700-7. PubMed ID: 24743904
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of adjuvant external beam radiotherapy for hepatocellular carcinoma following radical hepatectomy.
Wang L; Qiu L; Ke Q; Ji H; Wu J
Radiother Oncol; 2022 Oct; 175():101-111. PubMed ID: 35998838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
